Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 3/20 | 0.50 |
| ▸ | DGKA | P23743 | 2/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.50 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL495599 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL494938 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL18786502 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL496450 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL493915 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL494408 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL495250 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL495197 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL495181 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 | |
| SCHEMBL27819485 | 1.00 | MAPT (0.62) | MAPTLMNAALDH1A1KDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116918808-A | Application of fatty diacid ester compound | 沈阳恩柽研究院有限公司 | 2023-10-24 | — | — | CN | claimed |
| EP-4106743-A1 | AZELAIC ACID ESTERS IN THE TREATMENT OR PREVENTION OF DYSLIPIDEMIA AND ASSOCIATED CONDITIONS | New Frontier Labs, LLC (US) | 2022-12-28 | — | — | EP | claimed |
| CN-115397408-A | Azelaic acid esters for the treatment or prevention of dyslipidemia and related disorders | 新前沿实验室有限责任公司 | 2022-11-25 | — | — | CN | claimed |
| US-20210251939-A1 | AZELAIC ACID ESTERS IN THE TREATMENT OR PREVENTION OF DYSLIPIDEMIA AND ASSOCIATED CONDITIONS | NEW FRONTIER LABS, LLC | 2021-08-19 | — | — | US | claimed |
| EP-3087167-A1 | LOW VISCOSITY ESTER LUBRICANT AND METHOD FOR USING | ExxonMobil Research and Engineering Company (US) | 2016-11-02 | — | — | EP | claimed |
| US-20160130524-A1 | LOW VISCOSITY ESTER LUBRICANT AND METHOD FOR USING | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2016-05-12 | — | — | US | claimed |
| CN-104353265-B | Low-dosage environment-friendly seawater desalination engineering defoaming agent | JIANGSU SAIOUXINYUE DEFOAMER CO.,LTD. (CN) | 2016-03-09 | — | — | CN | claimed |
| WO-2015099907-A1 | LOW VISCOSITY ESTER LUBRICANT AND METHOD FOR USING | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2015-07-02 | — | — | WO | claimed |
| CN-104353265-A | Low-dosage and environment-friendly defoaming agent for seawater desalination engineering | JIANGSU SAIOUXINYUE DEFOAMER CO LTD | 2015-02-18 | — | — | CN | claimed |
| US-5795695-A | PHOTO-QUALITY RECORDING | XEROX CORPORATION (US) | 1998-08-18 | — | — | US | claimed |
| US-4764231-A | Well stimulation process and low velocity explosive formulation | ATLAS POWDER COMPANY (US) | 1988-08-16 | — | — | US | claimed |
| US-4102953-A | Method for making extruded, solventless, composite-modified double base propellant | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1978-07-25 | — | — | US | claimed |
| CN-121910713-A | Azelaic acid esters in the treatment or prevention of dyslipidemia and related disorders | 新前沿实验室有限责任公司 | 2026-04-24 | — | — | CN | disclosed |
| US-12605354-B2 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | NEW FRONTIER LABS, LLC (US) | 2026-04-21 | — | — | US | disclosed |
| US-12605354-B2 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | NEW FRONTIER LABS, LLC (US) | 2026-04-21 | — | — | US | disclosed |
| US-12329735-B2 | Azelaic acid esters in the treatment of insulin resistance | NEW FRONTIER LABS, LLC (US) | 2025-06-17 | — | — | US | disclosed |
| US-4082583-A | METRIOL TRINITRATE; TRIETHYLENE GLYCOL DINITRATE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1978-04-04 | — | — | US | disclosed |
| US-4064092-A | ADDITION POLYMER | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4051087-A | LAMINATES, ADHESIVES | PHILLIPS PETROLEUM COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
| US-3936403-A | Synthetic resin composition | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605354-B2 | Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions | LIPA, CETP, APOB | MAPT 3766/4885LMNA 1361/4885ALDH1A1 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.